MSK’s new colorectal cancer treatments cut death rates and protect quality of life in 2026 — but a rise in young-onset cases complicates the picture.
MSK’s new colorectal cancer treatments cut death rates and protect quality of life in 2026 — but a rise in young-onset cases complicates the picture.